Indications
Treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of amlodipine, valsartan and hydrochlorothiazide (HCT), taken either as three single-component formulations or as a dual-component and a single-component formulation.
Composition
- Active substance
- valsartan, hydrochlorothiazide, amlodipine besilate
- International name (INN)
- amlodipine besilate;valsartan;hydrochlorothiazide
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Dafiro HCT
- Active substance
- valsartan, hydrochlorothiazide, amlodipine besilate
- ATC code
- C09DX01